263 related articles for article (PubMed ID: 25752797)
1. Characterization of arsenic hepatobiliary transport using sandwich-cultured human hepatocytes.
Roggenbeck BA; Carew MW; Charrois GJ; Douglas DN; Kneteman NM; Lu X; Le XC; Leslie EM
Toxicol Sci; 2015 Jun; 145(2):307-20. PubMed ID: 25752797
[TBL] [Abstract][Full Text] [Related]
2. A novel pathway for arsenic elimination: human multidrug resistance protein 4 (MRP4/ABCC4) mediates cellular export of dimethylarsinic acid (DMAV) and the diglutathione conjugate of monomethylarsonous acid (MMAIII).
Banerjee M; Carew MW; Roggenbeck BA; Whitlock BD; Naranmandura H; Le XC; Leslie EM
Mol Pharmacol; 2014 Aug; 86(2):168-79. PubMed ID: 24870404
[TBL] [Abstract][Full Text] [Related]
3. Multidrug Resistance Protein 1 (MRP1/
Banerjee M; Kaur G; Whitlock BD; Carew MW; Le XC; Leslie EM
Drug Metab Dispos; 2018 Aug; 46(8):1096-1105. PubMed ID: 29752257
[TBL] [Abstract][Full Text] [Related]
4. Arsenic-glutathione conjugate transport by the human multidrug resistance proteins (MRPs/ABCCs).
Leslie EM
J Inorg Biochem; 2012 Mar; 108():141-9. PubMed ID: 22197475
[TBL] [Abstract][Full Text] [Related]
5. Polymorphic variants of MRP4/ABCC4 differentially modulate the transport of methylated arsenic metabolites and physiological organic anions.
Banerjee M; Marensi V; Conseil G; Le XC; Cole SP; Leslie EM
Biochem Pharmacol; 2016 Nov; 120():72-82. PubMed ID: 27659809
[TBL] [Abstract][Full Text] [Related]
6. Selenium-dependent and -independent transport of arsenic by the human multidrug resistance protein 2 (MRP2/ABCC2): implications for the mutual detoxification of arsenic and selenium.
Carew MW; Leslie EM
Carcinogenesis; 2010 Aug; 31(8):1450-5. PubMed ID: 20584751
[TBL] [Abstract][Full Text] [Related]
7. Biliary excretion of arsenic by human HepaRG cells is stimulated by selenide and mediated by the multidrug resistance protein 2 (MRP2/ABCC2).
Zhou JR; Kaur G; Ma Y; Arutyunov D; Lu X; Le XC; Leslie EM
Biochem Pharmacol; 2021 Nov; 193():114799. PubMed ID: 34678219
[TBL] [Abstract][Full Text] [Related]
8. Monomethylarsenic diglutathione transport by the human multidrug resistance protein 1 (MRP1/ABCC1).
Carew MW; Naranmandura H; Shukalek CB; Le XC; Leslie EM
Drug Metab Dispos; 2011 Dec; 39(12):2298-304. PubMed ID: 21918036
[TBL] [Abstract][Full Text] [Related]
9. Arsenic transport by the human multidrug resistance protein 1 (MRP1/ABCC1). Evidence that a tri-glutathione conjugate is required.
Leslie EM; Haimeur A; Waalkes MP
J Biol Chem; 2004 Jul; 279(31):32700-8. PubMed ID: 15161912
[TBL] [Abstract][Full Text] [Related]
10. Multidrug resistance proteins (MRPs, ABCCs): importance for pathophysiology and drug therapy.
Keppler D
Handb Exp Pharmacol; 2011; (201):299-323. PubMed ID: 21103974
[TBL] [Abstract][Full Text] [Related]
11. Species differences in hepatobiliary disposition of taurocholic acid in human and rat sandwich-cultured hepatocytes: implications for drug-induced liver injury.
Yang K; Pfeifer ND; Köck K; Brouwer KL
J Pharmacol Exp Ther; 2015 May; 353(2):415-23. PubMed ID: 25711339
[TBL] [Abstract][Full Text] [Related]
12. Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway.
Maher JM; Dieter MZ; Aleksunes LM; Slitt AL; Guo G; Tanaka Y; Scheffer GL; Chan JY; Manautou JE; Chen Y; Dalton TP; Yamamoto M; Klaassen CD
Hepatology; 2007 Nov; 46(5):1597-610. PubMed ID: 17668877
[TBL] [Abstract][Full Text] [Related]
13. Formation and efflux of ATP-binding cassette transporter substrate 2,4-dinitrophenyl-S-glutathione from cultured human term placental villous tissue fragments.
Vaidya SS; Walsh SW; Gerk PM
Mol Pharm; 2009; 6(6):1689-702. PubMed ID: 19397308
[TBL] [Abstract][Full Text] [Related]
14. Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane.
Rius M; Nies AT; Hummel-Eisenbeiss J; Jedlitschky G; Keppler D
Hepatology; 2003 Aug; 38(2):374-84. PubMed ID: 12883481
[TBL] [Abstract][Full Text] [Related]
15. Contribution of multidrug resistance protein 2 (MRP2/ABCC2) to the renal excretion of p-aminohippurate (PAH) and identification of MRP4 (ABCC4) as a novel PAH transporter.
Smeets PH; van Aubel RA; Wouterse AC; van den Heuvel JJ; Russel FG
J Am Soc Nephrol; 2004 Nov; 15(11):2828-35. PubMed ID: 15504935
[TBL] [Abstract][Full Text] [Related]
16. Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development.
Zhou SF; Wang LL; Di YM; Xue CC; Duan W; Li CG; Li Y
Curr Med Chem; 2008; 15(20):1981-2039. PubMed ID: 18691054
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic Modeling of the Hepatic Disposition of Estradiol-17
Ito K; Sjöstedt N; Brouwer KLR
Drug Metab Dispos; 2020 Feb; 48(2):116-122. PubMed ID: 31744810
[TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance-associated protein 4 is a determinant of arsenite resistance.
Yuan B; Yoshino Y; Fukushima H; Markova S; Takagi N; Toyoda H; Kroetz DL
Oncol Rep; 2016 Jan; 35(1):147-54. PubMed ID: 26497925
[TBL] [Abstract][Full Text] [Related]
19. Hepatic Disposition of Gemfibrozil and Its Major Metabolite Gemfibrozil 1-O-β-Glucuronide.
Kimoto E; Li R; Scialis RJ; Lai Y; Varma MV
Mol Pharm; 2015 Nov; 12(11):3943-52. PubMed ID: 26378985
[TBL] [Abstract][Full Text] [Related]
20. Mathematical modeling of the in vitro hepatic disposition of mycophenolic acid and its glucuronide in sandwich-cultured human hepatocytes.
Matsunaga N; Wada S; Nakanishi T; Ikenaga M; Ogawa M; Tamai I
Mol Pharm; 2014 Feb; 11(2):568-79. PubMed ID: 24320552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
